Found 7 matching trials
Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma
PHASE2Recent studies suggest that patients with metastatic melanoma whose gut mic...
FMT With Nivolumab in Patients With Advanced Solid Cancers Who Have Progressed During Anti-PD-(L)1 Therapy
NAThis is a single-center, open-label, Phase 2 study to evaluate the efficacy...
Location
Asan Medical Center
Gut Microbiota Reconstruction for NSCLC Immunotherapy
PHASE1In this study, patients with locally advanced or metastatic NSCLC after fir...
Location
Zhongshan Hospital, Fudan University
Fecal Microbial Transplantation Non-Small Cell Lung Cancer and Melanoma
PHASE2The aim of this study is to assess the anti-tumor activity of FMT administe...
Status
Active Not Recruiting
Location
London Health Sciences Centre
Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation
PHASE1Cancer immunotherapy has been largely adopted in oncology patient managemen...
Status
Active Not Recruiting
Location
London Regional Cancer Program of the Lawson Health Research Institute
Study of FMT Combined With Nivolumab in Gastric Cancer
NAThis study is a single-arm, single center study. The purpose of this study ...
Location
Fujian Cancer Hospital
Fecal Microbiota Transplant (FMT) in Melanoma Patients
PHASE2The main goal of this research study is to determine if the fecal microbiot...
Location
UPMC Hillman Cancer Center